Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.
Open Access
- 1 May 1978
- Vol. 19 (5) , 408-413
- https://doi.org/10.1136/gut.19.5.408
Abstract
Urogastrone has been localised by immunostaining to granules of the cells of human duodenal (Brunner's) glands and their ducts and of acinar cells in the human submandibular gland. The immunoreactive peptide is present in large quantities in duodenal glands and their secretory ducts. Urogastrone or human epidermal growth factor promotes cellular proliferation in vivo as well as in vitro and inhibits gastric acid secretion and may, therefore, be one of the duodenal factors inhibiting gastric activity. Thus it may have an important regulatory and protective function for the intestinal mucosa and may possibly become a useful therapeutic agent.This publication has 21 references indexed in Scilit:
- Mouse epidermal growth factor: Light and electron microscopical localisation by immunocytochemical stainingHistochemistry and Cell Biology, 1977
- Urogastrone Levels in the Urine of Normal Adult HumansJournal of Clinical Endocrinology & Metabolism, 1977
- THE PRIMARY STRUCTURE OF HUMAN UROGASTRONEInternational Journal of Peptide and Protein Research, 1977
- Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblastsLife Sciences, 1977
- Proceedings: Cellular localization urogastrone by an immunofluorescent technique.1976
- Human epidermal growth factor and the proliferation of human fibroblastsJournal of Cellular Physiology, 1976
- Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects.Gut, 1975
- EFFECT OF UROGASTRONE IN THE ZOLLINGER-ELLISON SYNDROMEThe Lancet, 1975
- Bifunctional reagents as vapour- and liquid-phase fixatives for immunohistochemistryJournal of Molecular Histology, 1975
- Inhibition of Gastric Secretion by Extracts of Normal Male UrineScience, 1939